Bisphosphonates in Medical Practice : Actions : Side Effects : Indications : Strategies
https://libcat.nshealth.ca/en/permalink/provcat28438
by Reiner Bartl, Bertha Frisch, Emmo Tresckow, Christoph Bartl.
--Berlin, Heidelberg:
Springer-Verlag
, c2007.
- Available Online
- View e-Book
- Location
- Online
- Available Online
- View e-Book
- Author
- Bartl, Reiner
- Other Authors
- Frisch, Bertha
- Tresckow, Emmo
- Bartl, Christoph
- Responsibility
- by Reiner Bartl, Bertha Frisch, Emmo Tresckow, Christoph Bartl
- Place of Publication
- Berlin, Heidelberg
- Publisher
- Springer-Verlag
- Date of Publication
- c2007
- ISBN
- 9783540698708
- Subjects (MeSH)
- Bone Diseases - drug therapy
- Diphosphonates - adverse effects
- Diphosphonates - therapeutic use
- Subjects (LCSH)
- Biochemistry
- Orthopedics
- Format
- e-Book
- Location
- Online
Osteoporosis : Diagnosis, Prevention, Therapy
https://libcat.nshealth.ca/en/permalink/provcat28436
by Reiner Bartl, Bertha Frisch.
(2nd rev. ed.)
--Berlin, Heidelberg:
Springer
, c2009.
- Available Online
- View e-Book
- Location
- Online
- Available Online
- View e-Book
- Author
- Bartl, Reiner
- Other Authors
- Frisch, Bertha
- Responsibility
- by Reiner Bartl, Bertha Frisch
- Edition
- 2nd rev. ed.
- Place of Publication
- Berlin, Heidelberg
- Publisher
- Springer
- Date of Publication
- c2009
- ISBN
- 9783540795278
- Subjects (MeSH)
- Osteoporosis
- Bone Density
- Diphosphonates - therapeutic use
- Hormone replacement therapy
- Subjects (LCSH)
- Orthopedics
- Format
- e-Book
- Location
- Online
Prevention of Bone Metastases
https://libcat.nshealth.ca/en/permalink/provcat31127
Markus Joerger, Michael Gnant, editors.
--Berlin, Heidelberg:
Springer
, c2012.
- Available Online
- View e-Book
- Location
- Online
Bone metastases continue to be a major cause of morbidity in cancer patients, but improved understanding of the biology of bone metastases has led to the identification of drugs that are of potential value in not only their treatment but also their prevention. This book, written by recognized experts in the field, provides a detailed overview of current knowledge on this subject. One important focus of the book is the efficacy of bisphosphonates in preventing bone metastases in patients with br…
- Available Online
- View e-Book
- Other Authors
- Joerger, Markus
- Gnant, Michael
- Responsibility
- Markus Joerger, Michael Gnant, editors
- Place of Publication
- Berlin, Heidelberg
- Publisher
- Springer
- Date of Publication
- c2012
- Physical Description
- 1 online resource (ix, 233 p. : 23 ill., 13 ill. in color)
- Series Vol.
- 192
- Series Title
- Recent results in cancer research
- ISBN
- 9783642218927
- Subjects (MeSH)
- Biological Markers
- Bone Neoplasms - prevention & control
- Bone Neoplasms - secondary
- Cytostatic Agents - therapeutic use
- Diphosphonates - therapeutic use
- Subjects (LCSH)
- Oncology
- Abstract
- Bone metastases continue to be a major cause of morbidity in cancer patients, but improved understanding of the biology of bone metastases has led to the identification of drugs that are of potential value in not only their treatment but also their prevention. This book, written by recognized experts in the field, provides a detailed overview of current knowledge on this subject. One important focus of the book is the efficacy of bisphosphonates in preventing bone metastases in patients with breast, lung, and prostate cancer and disease progression in cases of multiple myeloma. The combined use of bisphosphonates and cytostatics is also discussed, with a report on first clinical data. Further topics addressed include the significance of the bone microenvironment, special issues in the elderly patient, the use of bone turnover markers, and initial findings obtained with denosumab.
- Contents
- Preclinical Models that Illuminate the Bone Metastasis Cascade -- The Role of Bone Microenvironment, Vitamin D and Calcium -- Bisphosphonates: Prevention of Bone Metastases in Breast Cancer -- Bisphosphonates: Prevention of Bone Metastases in Lung Cancer -- Bisphosphonates: Prevention of Bone Metastases in Prostate Cancer -- Targeting Bone in Myeloma -- Combinations of Bisphosphonates and Classical Anticancer Drugs: A Preclinical Perspective -- Perspectives in the Elderly Patient: Benefits and Limits of Bisphosphonates and Denosumab -- Denosumab: First Data and Ongoing Studies on the Prevention of Bone Metastases -- Diagnostic and Prognostic Use of Bone Turnover Markers -- Osteolytic and Osteoblastic Bone Metastases: Two Extremes of the Same Spectrum?
- Format
- e-Book
- Location
- Online
